Status:
COMPLETED
Dose-Response Study of Probiotic Bacteria BB-12 and CRL-431 in Healthy Young Adults
Lead Sponsor:
University of Copenhagen
Conditions:
Cardiovascular Disease
Constipation
Eligibility:
All Genders
18-40 years
Phase:
PHASE1
Brief Summary
The purpose of the study was to investigate the dose-response effect of increasing doses of Bifidobacterium animalis ssp lactis (BB-12) and Lactobacillus paracasei ssp paracasei (CRL-431) on the immun...
Detailed Description
The study included seventy-one healthy young vounteers, and was designed as a double-blind placebo controlled dose-response trial based on a 2 wk run-in period, a 3 wk intervention and 2 wk wash-out p...
Eligibility Criteria
Inclusion
- Healthy young individuals
Exclusion
- GI-disease
- Colosomi
- Pregnant or lactating women
- Allergy
- Individuals receiving the following medicine: antacid, antibiotics, steroids, medicine with influence the intestinal function.
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
End Date :
November 1 2003
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT00611299
Start Date
April 1 2003
End Date
November 1 2003
Last Update
March 18 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Human Nutrition
Frederiksberg C, Denmark, 1958